MRT Inkomsten in het verleden
Verleden criteriumcontroles 1/6
MRT has been growing earnings at an average annual rate of 25%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 19% per year. MRT's return on equity is 0.6%, and it has net margins of 0.7%.
Belangrijke informatie
25.0%
Groei van de winst
25.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 7.9% |
| Inkomstengroei | 19.0% |
| Rendement op eigen vermogen | 0.6% |
| Nettomarge | 0.7% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe MRT geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 4,387 | 32 | 2,507 | 0 |
| 31 Mar 24 | 4,579 | 160 | 2,421 | 0 |
| 31 Dec 23 | 5,407 | 517 | 2,304 | 0 |
| 30 Sep 23 | 6,097 | 1,024 | 2,410 | 0 |
| 30 Jun 23 | 6,533 | 1,307 | 2,383 | 0 |
| 31 Mar 23 | 8,169 | 1,876 | 2,431 | 0 |
| 31 Dec 22 | 8,738 | 2,159 | 2,436 | 0 |
| 30 Sep 22 | 8,200 | 1,801 | 2,258 | 0 |
| 30 Jun 22 | 8,269 | 1,937 | 2,321 | 0 |
| 31 Mar 22 | 6,272 | 1,390 | 2,117 | 0 |
| 31 Dec 21 | 4,469 | 774 | 1,948 | 0 |
| 30 Sep 21 | 3,892 | 731 | 1,748 | 0 |
| 30 Jun 21 | 2,914 | 256 | 1,477 | 0 |
| 31 Mar 21 | 2,514 | 83 | 1,376 | 0 |
| 31 Dec 20 | 2,562 | 131 | 1,338 | 0 |
| 31 Dec 19 | 2,478 | 25 | 1,371 | 0 |
| 30 Sep 19 | 2,374 | 35 | 1,456 | 0 |
| 30 Jun 19 | 2,236 | 81 | 1,444 | 0 |
| 31 Mar 19 | 2,232 | 97 | 1,470 | 0 |
| 31 Dec 18 | 2,098 | 173 | 1,347 | 0 |
| 30 Sep 18 | 1,930 | 129 | 1,274 | 0 |
| 30 Jun 18 | 1,815 | 68 | 1,151 | 0 |
| 31 Mar 18 | 1,501 | 31 | 989 | 0 |
| 31 Dec 17 | 1,435 | 5 | 950 | 0 |
| 30 Sep 17 | 1,350 | 71 | 839 | 0 |
| 30 Jun 17 | 1,256 | 80 | 776 | 0 |
| 31 Mar 17 | 1,154 | 88 | 722 | 0 |
| 31 Dec 16 | 1,074 | 114 | 693 | 0 |
| 31 Mar 16 | 1,001 | 140 | 624 | 0 |
Kwaliteitswinsten: 6034 has a large one-off gain of ¥39.0M impacting its last 12 months of financial results to 30th June, 2024.
Groeiende winstmarge: 6034's current net profit margins (0.7%) are lower than last year (20%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 6034's earnings have grown significantly by 25% per year over the past 5 years.
Versnelling van de groei: 6034's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 6034 had negative earnings growth (-97.6%) over the past year, making it difficult to compare to the Healthcare industry average (9.6%).
Rendement op eigen vermogen
Hoge ROE: 6034's Return on Equity (0.6%) is considered low.